The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
Phase of Trial: Phase III
Latest Information Update: 02 May 2017
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Acute heart failure
- Focus Therapeutic Use
- Acronyms TACTICS-HF
- 13 Sep 2016 Primary endpoint (Dyspnea improvement measured by Likert scale at 8 and 24 hours) has not been met according to the results published in the Journal of the American College of Cardiology.
- 13 Sep 2016 Results published in the Journal of the American College of Cardiology.
- 10 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.